Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
10.03
-0.10 (-0.99%)
At close: Jul 24, 2026, 4:00 PM EDT
10.00
-0.03 (-0.30%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $487.34 million as of July 24, 2026. Its market cap has increased by 523.15% in one year.
Market Cap
487.34M
Enterprise Value
410.82M
1-Year Change
523.15%
Ranking
Category
Stock Price
$10.03
ChartMarket Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $487.34M, an increase of 175.71%. That is a compound annual growth rate of 65.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 487.34M | 362.82% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 537.24M |
| Prime Medicine | 536.43M |
| Adlai Nortye | 528.80M |
| Arvinas | 523.91M |
| Eikon Therapeutics | 520.81M |
| Ginkgo Bioworks Holdings | 518.02M |
| SL Science Holding | 512.35M |
| Zura Bio | 502.54M |